Literature DB >> 20003112

Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatment.

N M Feely1, D J Waghorn, T Dexter, I Gallen, P Chiodini.   

Abstract

Immunocompromised patients who are infected with Strongyloides stercoralis may develop a potentially fatal auto-infection syndrome characterised by non-specific pulmonary and gastrointestinal symptoms and Gram negative sepsis. We present the case of one such patient who underwent a negative laparotomy for a presumed intra-abdominal surgical catastrophe with a subsequent protracted stay on the intensive care unit. Once the diagnosis of strongyloidiasis was made, the patient was successfully treated with subcutaneous antihelminthic drugs. With appropriate screening for and eradication of strongyloides in those with immune compromise, or in those about to start immunosuppressive therapy, potentially fatal episodes of hyperinfection could be avoided. In the absence of screening, severe strongyloidiasis should be suspected in immunosuppressed individuals who have travelled to or resided in an endemic area and present with the characteristic features. Awareness of the signs of hyperinfection amongst those involved in acute care could prevent unnecessary morbidity and mortality in these patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20003112     DOI: 10.1111/j.1365-2044.2009.06196.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  9 in total

1.  Imported strongyloidiasis: epidemiology, presentations, and treatment.

Authors:  Dora Buonfrate; Andrea Angheben; Federico Gobbi; Jose Muñoz; Ana Requena-Mendez; Eduardo Gotuzzo; Maria Alejandra Mena; Zeno Bisoffi
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

2.  Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment.

Authors:  Tatvam T Choksi; Gul Madison; Tawseef Dar; Mohammed Asif; Kevin Fleming; Leon Clarke; Mervyn Danilewitz; Randa Hennawy
Journal:  Am J Trop Med Hyg       Date:  2016-08-15       Impact factor: 2.345

3.  Hyperinfection with Strongyloides stercoralis.

Authors:  Raúl Romero-Cabello; Javier Villagroy Gómez; Mercedes Hernández González; Raúl Romero Feregrino
Journal:  BMJ Case Rep       Date:  2012-11-30

Review 4.  Rapid development of migratory, linear, and serpiginous lesions in association with immunosuppression.

Authors:  Dominique C Pichard; Jennifer R Hensley; Esther Williams; Andrea B Apolo; Amy D Klion; John J DiGiovanna
Journal:  J Am Acad Dermatol       Date:  2014-06       Impact factor: 11.527

5.  In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis.

Authors:  Ana L Legarda-Ceballos; Julio López-Abán; Esther Del Olmo; Ricardo Escarcena; Luis A Bustos; Jose Rojas-Caraballo; Belén Vicente; Pedro Fernández-Soto; Arturo San Feliciano; Antonio Muro
Journal:  Parasit Vectors       Date:  2016-06-28       Impact factor: 3.876

6.  Pulmonary Strongyloidiasis Masquerading as Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Gourahari Pradhan; Priyadarshini Behera; Manoj Kumar Panigrahi; Sourin Bhuniya; Prasanta Raghab Mohapatra; Jyotirmayee Turuk; Srujana Mohanty
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-10-05

7.  Strongyloidiasis in a Patient Diagnosed by Metagenomic Next-Generation Sequencing: A Case Report.

Authors:  Junyan Qu; Zhiyong Zong
Journal:  Front Med (Lausanne)       Date:  2022-04-07

Review 8.  Severe strongyloidiasis: a systematic review of case reports.

Authors:  Dora Buonfrate; Ana Requena-Mendez; Andrea Angheben; Jose Muñoz; Federico Gobbi; Jef Van Den Ende; Zeno Bisoffi
Journal:  BMC Infect Dis       Date:  2013-02-08       Impact factor: 3.090

Review 9.  Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests.

Authors:  Sören L Becker; Jürg Vogt; Stefanie Knopp; Marcus Panning; David C Warhurst; Katja Polman; Hanspeter Marti; Lutz von Müller; Cedric P Yansouni; Jan Jacobs; Emmanuel Bottieau; Moussa Sacko; Suman Rijal; Fransiska Meyanti; Michael A Miles; Marleen Boelaert; Pascal Lutumba; Lisette van Lieshout; Eliézer K N'Goran; François Chappuis; Jürg Utzinger
Journal:  BMC Infect Dis       Date:  2013-01-24       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.